Tactile Systems reports Q1 EPS (13c), consensus (6c)

Reports Q1 revenue $61.27M, consensus $63.48M. “Through the first quarter our team executed on several highly strategic, growth-oriented priorities. We launched Nimbl for lower extremity lymphedema, completed efforts to optimize our sales organization for scale and efficiency, and implemented a new CRM tool that equips our team with best-in-class resources to more efficiently reach lymphedema patients,” said Sheri Dodd, CEO of Tactile Medical.